Currently the main cause of cervical cancer – the fourth most common cancer in women globally – HPV is a very common group of viruses that leads to cervical cancer in more than nine out of every ten cases.
Despite already-existing WHO-prequalified vaccines, including Merck & Co’s – known as MSD outside the US and Canada – Gardasil 9 (HPV 9-valent, recombinant) and GSK’s Cervarix (HPV bivalent (types 16, 18) vaccine, recombinant), to prevent HPV infections, there are currently no vaccines that can treat them…
